UNSPSC 51452303: Desaspidin

This classification denotes an antihelminthic agent with the molecular formula C24H30O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KV3495SGKS, chemically known as 3-((5-butyryl-2,4-dihydroxy-3,3-dimethyl-6-oxo-1,4-cyclohexadien-1-yl)methyl)-2,6-dihydroxy-4-methoxybutyrophenone but generally known as desaspidin, which bears US NIH Compound Identifier 8238. European Medicines Agency schedules Desaspidin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06989MIG.

UNSPSC 51452303 Desaspidin, a Commodity code, does not align with actual state and local procurement activity reflected in recent solicitations tagged under it. The code nominally describes desaspidin, a pharmaceutical anthelmintic agent, yet the recent opportunities posted under this code request naloxone (an opioid antagonist), safe drug deactivation systems, generic multi-source pharmaceuticals and OTC products, medical and first aid supplies, and direct-to-manufacturer prescription program capabilities—none of which are desaspidin or related to anthelmintic treatment. State and local buyers tagging opportunities under 51452303 appear to be using the code as a catch-all for pharmaceutical procurement rather than as a specific product line. Issuing bodies include county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing alliances. The code shows activity from Seminole County, Florida; the City of Tampa; the Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), serving multiple state jurisdictions.

Geographic activity spans Florida, Texas, Minnesota, and Oregon through the MMCAP cooperative vehicle. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's sheltered-market IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract amount of $700,000 and a 5 percent bid discount reserved for certified Small Local Business Enterprises; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) exploring direct-to-manufacturer prescription programs; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across state and local facilities. The code's nominal scope and the actual work being solicited diverge significantly, making this code a poor targeting vehicle for firms specializing in desaspidin or anthelmintic products.